Thursday’s Top Biotech & Medical Stocks
by H.S. AyoubBioHealth Investor.com Biotechnology OPEXA THERAPEUTICS +23.40% POLYMEDIX INC +18.38% PIPEX PHARMACEUT NEW +16.01% BIOENVISION INC +12.79% MEMORY PHARMACEUTICA +8.15% Diagnostic Substances REMOTEMDX INC +9.68% TORREYPINES THERAPEU +6.92% EPICEPT CORPORATION +3.97% ISTA PHARMACTLS +2.89% EPIX PHARMACEUTICALS +2.75% Drug Delivery…
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
by H.S. Ayoub
BioHealth Investor.com
Biotechnology
OPEXA THERAPEUTICS [OPXA] +23.40%
POLYMEDIX INC [PYMX.OB] +18.38%
PIPEX PHARMACEUT NEW [PPEX.OB] +16.01%
BIOENVISION INC [BIVN] +12.79%
MEMORY PHARMACEUTICA [MEMY] +8.15%
Diagnostic Substances
REMOTEMDX INC [RMDX.OB] +9.68%
TORREYPINES THERAPEU [TPTX] +6.92%
EPICEPT CORPORATION [EPCT] +3.97%
ISTA PHARMACTLS [ISTA] +2.89%
EPIX PHARMACEUTICALS [EPIX] +2.75%
Drug Delivery
IOMED INC [IOX] +2.58%
BIOPROGRESS PLC [BPRG] +2.53%
BENTLEY PHARMACEUTIC [BNT] +2.48%
K V PHARMA CL A [KV-A] +2.22%
ELAN CP PLC ADR [ELN] +1.59%
Drug Manufacturers
DUSA PHARM INC [DUSA] +71.90%
AVANIR PHARMACEUTICL [AVNR] +21.76%
NEXMED INC [NEXM] +18.81%
GERON CORP [GERN] +15.05%
NEUROCHEM INC [NRMX] +7.61%
Drug Related Products
ZILA INC [ZILA] +1.10%
NATURAL ALTERNATIV [NAII] +0.65%
N B T Y INC [NTY] +0.43%
Generic Drugs
ISOLAGEN INC [ILE] +2.47%
PHARMACUTICAL CO [PRX] +1.59%
BARR PHARMA INC [BRL] +1.36%
CATALYST PHARMACEUTI [CPRX] +0.46%
WATSON PHARMACEUTCLS [WPI] +0.06%
Medical Appliances & Equipment
CELSION CORP [CLN] +15.66%
SONTRA MEDICAL CORP [SONT.OB] +9.23%
REGENERATION TECH [RTIX] +7.50%
AMER MED ALERT CP [AMAC] +5.71%
RESTORE MEDICAL INC [REST] +3.54%
Medical Instruments & Supplies
HEMOSENSE INC. [HEM] +11.95%
APA ENTERPRISES [APAT] +8.59%
EP MEDSYSTEMS INC [EPMD] +8.57%
ALPHATEC HOLDINGS [ATEC] +8.21%
IVAX DIAGNOSTICS INC [IVD] +7.96%
Medical Laboratories & Research
RADNET INC [RDNT] +3.28%
PHARM PROD DEV [PPDI] +2.99%
NATL DENTEX CP [NADX] +1.50%
AETERNA ZENTARIS [AEZS] +0.84%
BIO-IMAGING TECH [BITI] +0.46%
Contact [email protected] for any questions or corrections.
Douglas A. McIntyre is the co-founder, chief executive officer and editor in chief of 24/7 Wall St. and 24/7 Tempo. He has held these jobs since 2006.
McIntyre has written thousands of articles for 24/7 Wall St. He is an expert on corporate finance, the automotive industry, media companies and international finance. He has edited articles on national demographics, sports, personal income and travel.
His work has been quoted or mentioned in The New York Times, The Wall Street Journal, Los Angeles Times, The Washington Post, NBC News, Time, The New Yorker, HuffPost USA Today, Business Insider, Yahoo, AOL, MarketWatch, The Atlantic, Bloomberg, New York Post, Chicago Tribune, Forbes, The Guardian and many other major publications. McIntyre has been a guest on CNBC, the BBC and television and radio stations across the country.
A magna cum laude graduate of Harvard College, McIntyre also was president of The Harvard Advocate. Founded in 1866, the Advocate is the oldest college publication in the United States.
TheStreet.com, Comps.com and Edgar Online are some of the public companies for which McIntyre served on the board of directors. He was a Vicinity Corporation board member when the company was sold to Microsoft in 2002. He served on the audit committees of some of these companies.
McIntyre has been the CEO of FutureSource, a provider of trading terminals and news to commodities and futures traders. He was president of Switchboard, the online phone directory company. He served as chairman and CEO of On2 Technologies, the video compression company that provided video compression software for Adobe’s Flash. Google bought On2 in 2009.